Cargando…
Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis
BACKGROUND: To date, various treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP) have been reported. We performed a systematic review and meta-analysis to evaluate the efficacy and safety of current treatments for RP-CME. METHODS: PubMed, Embase and the Cochrane library were sear...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149278/ https://www.ncbi.nlm.nih.gov/pubmed/35652079 http://dx.doi.org/10.3389/fmed.2022.895208 |
_version_ | 1784717175354818560 |
---|---|
author | Chen, Chen Liu, Xia Peng, Xiaoyan |
author_facet | Chen, Chen Liu, Xia Peng, Xiaoyan |
author_sort | Chen, Chen |
collection | PubMed |
description | BACKGROUND: To date, various treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP) have been reported. We performed a systematic review and meta-analysis to evaluate the efficacy and safety of current treatments for RP-CME. METHODS: PubMed, Embase and the Cochrane library were searched from inception to August 2021. ClinicalTrials.gov, WHO ICTRP and ISRCTN were also searched for relevant studies. Only studies published in English were included. The RoB 2 tool was used to evaluate the risk of bias of randomized controlled trials (RCTs), and the MINORS scale was used to assess the methodological quality of non-RCTs. Review manager (Revman) was used to pool the data. The primary outcomes included the change of central macular thickness (CMT) and best-corrected visual acuity (BCVA) from baseline. The secondary outcomes included fluorescein angiography (FA) leakage, rebound of CME and adverse effects. RESULTS: Thirty-two studies were included in the current systematic review and 7 studies were used for meta-analysis. Treatments for RP-CME included oral and topical carbonic anhydrase inhibitors (CAIs), systematic and local steroids, anti-VEGF therapy, NSAIDS, grid LASER photocoagulation, subliminal micropulse LASER, vitrectomy, lutein supplement and oral minocycline. CAIs and local steroids were proved to be effective in reducing CMT. The effects of anti-VEGF reagents varied among studies. Regarding other treatments, only one study for each method fitted the inclusion criteria, so the evidence was very limited. CONCLUSION: Topical CAIs, oral CAIs and local steroids are effective in treating RP-CME. However, due to the overall inferior design and small patient number of the included studies, the quality of evidence was poor. Systematic steroids, LASER, NSAIDS and vitrectomy may also be effective, nevertheless, considering the limited number of studies, no conclusion could be drawn regarding these treatments. More well-designed and conducted studies are needed in this field. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021273979, identifier CRD42021273979. |
format | Online Article Text |
id | pubmed-9149278 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91492782022-05-31 Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis Chen, Chen Liu, Xia Peng, Xiaoyan Front Med (Lausanne) Medicine BACKGROUND: To date, various treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP) have been reported. We performed a systematic review and meta-analysis to evaluate the efficacy and safety of current treatments for RP-CME. METHODS: PubMed, Embase and the Cochrane library were searched from inception to August 2021. ClinicalTrials.gov, WHO ICTRP and ISRCTN were also searched for relevant studies. Only studies published in English were included. The RoB 2 tool was used to evaluate the risk of bias of randomized controlled trials (RCTs), and the MINORS scale was used to assess the methodological quality of non-RCTs. Review manager (Revman) was used to pool the data. The primary outcomes included the change of central macular thickness (CMT) and best-corrected visual acuity (BCVA) from baseline. The secondary outcomes included fluorescein angiography (FA) leakage, rebound of CME and adverse effects. RESULTS: Thirty-two studies were included in the current systematic review and 7 studies were used for meta-analysis. Treatments for RP-CME included oral and topical carbonic anhydrase inhibitors (CAIs), systematic and local steroids, anti-VEGF therapy, NSAIDS, grid LASER photocoagulation, subliminal micropulse LASER, vitrectomy, lutein supplement and oral minocycline. CAIs and local steroids were proved to be effective in reducing CMT. The effects of anti-VEGF reagents varied among studies. Regarding other treatments, only one study for each method fitted the inclusion criteria, so the evidence was very limited. CONCLUSION: Topical CAIs, oral CAIs and local steroids are effective in treating RP-CME. However, due to the overall inferior design and small patient number of the included studies, the quality of evidence was poor. Systematic steroids, LASER, NSAIDS and vitrectomy may also be effective, nevertheless, considering the limited number of studies, no conclusion could be drawn regarding these treatments. More well-designed and conducted studies are needed in this field. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021273979, identifier CRD42021273979. Frontiers Media S.A. 2022-05-16 /pmc/articles/PMC9149278/ /pubmed/35652079 http://dx.doi.org/10.3389/fmed.2022.895208 Text en Copyright © 2022 Chen, Liu and Peng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Chen, Chen Liu, Xia Peng, Xiaoyan Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis |
title | Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis |
title_full | Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis |
title_fullStr | Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis |
title_short | Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis |
title_sort | management of cystoid macular edema in retinitis pigmentosa: a systematic review and meta-analysis |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149278/ https://www.ncbi.nlm.nih.gov/pubmed/35652079 http://dx.doi.org/10.3389/fmed.2022.895208 |
work_keys_str_mv | AT chenchen managementofcystoidmacularedemainretinitispigmentosaasystematicreviewandmetaanalysis AT liuxia managementofcystoidmacularedemainretinitispigmentosaasystematicreviewandmetaanalysis AT pengxiaoyan managementofcystoidmacularedemainretinitispigmentosaasystematicreviewandmetaanalysis |